About the Cancer Prognosis Session
A disease's prognosis is an estimate of the disease's anticipated course and outcome. Cancer prognosis usually refers to the likelihood of recovery and success with treatment. Many things can influence a cancer patient's prognosis. The type and location of the cancer, the cancer stage (the extent to which the cancer has spread throughout the body), and the cancer's grade (how abnormal the cancer cells appear under a microscope—an indicator of how quickly the cancer is likely to grow and spread) are among the most important factors. After taking into account the factors that influence prognosis, a patient's expected five-year survival is computed. This incorporates all elements such as available treatment options and other health issues that could affect the disease's successful treatment.
- Factors affecting prognosis
- Biomarkers and prognosis
- Depicting cancer prognosis
Topics Covered in Cancer Prognosis
Stage & Grade
Prognostic Biomarkers
Survival Analysis
Performance Status
Risk Prediction Models
Recurrence Risk
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Prognosis Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Prognosis work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Prognosis research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Prognosis track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Prognosis Conference 2027 — FAQs
What is the Cancer Prognosis track at CIOC 2027?
The Cancer Prognosis track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Prognosis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Prognosis sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Prognosis are all welcome — whether presenting or attending.
Can I present my research in the Cancer Prognosis track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Prognosis sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Prognosis track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.